Oncolytics Biotech-Nobilis Health-David Morgan and Dudley Baker

Today on the program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll then chat with Harry Fleming, the President of Texas based Nobilis Health Trading on the TSX as NHC. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. We’ve seen their share price nearly triple since they began as a sponsor with us in January. David Morgan, of The Morgan report joins Ellis for a conversation about commodities…and he has a startling prediction for the energy sector and oil derivatives and the coming effect on the economy. We’ll finish the show with Dudley Baker of common stock warrants.com and now the marijuana speculator for a first look at that controversial space on this program.